Overview

A Study of HBS-201 (Pitolisant Delayed-release)

Status:
RECRUITING
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the tolerability of HBS-201 when starting at a therapeutic dose in adult participants with narcolepsy.
Phase:
PHASE1
Details
Lead Sponsor:
Harmony Biosciences Management, Inc.